Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma.

MicroRNAs (miRNAs) are small, single-stranded, non-coding RNAs that play pivotal roles in human cancer development and progression, such as tumor metastasis. Here, we identified the miRNAs that regulate hepatocellular carcinoma (HCC) cell migration by a high-throughput screening method using the cla...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ruopeng Zha, Weijie Guo, Zhenfeng Zhang, Zhaoping Qiu, Qifeng Wang, Jie Ding, Shenglin Huang, Taoyang Chen, Jianren Gu, Ming Yao, Xianghuo He
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/835c6f752bc548d2a04ed466c2e47883
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:835c6f752bc548d2a04ed466c2e47883
record_format dspace
spelling oai:doaj.org-article:835c6f752bc548d2a04ed466c2e478832021-11-18T08:34:14ZGenome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma.1932-620310.1371/journal.pone.0087665https://doaj.org/article/835c6f752bc548d2a04ed466c2e478832014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24498348/?tool=EBIhttps://doaj.org/toc/1932-6203MicroRNAs (miRNAs) are small, single-stranded, non-coding RNAs that play pivotal roles in human cancer development and progression, such as tumor metastasis. Here, we identified the miRNAs that regulate hepatocellular carcinoma (HCC) cell migration by a high-throughput screening method using the classical wound-healing assay with time-lapse video microscopy and validation with a transwell migration assay. Eleven miRNAs (miR-134, -146b-3p, -188-3p, -525-3p, -661, -767-5p, -891a, -891b, -1244, -1247 and miR-1471) were found to promote or inhibit HCC cell migration. Further investigation revealed that miR-134 suppressed the invasion and metastasis of HCC cells in vitro and in vivo, and integrin beta 1 (ITGB1) was a direct and functional target gene of miR-134. Moreover, miR-134 inhibited the phosphorylation of focal adhesion kinase (FAK) and the activation of RhoA downstream of the ITGB1 pathway, thereby decreasing stress fiber formation and cell adhesion in HCC cells. In conclusion, we demonstrated that miR-134 is a novel metastasis suppressor in HCC and could be a potential therapeutic target for the treatment of HCC.Ruopeng ZhaWeijie GuoZhenfeng ZhangZhaoping QiuQifeng WangJie DingShenglin HuangTaoyang ChenJianren GuMing YaoXianghuo HePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 2, p e87665 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ruopeng Zha
Weijie Guo
Zhenfeng Zhang
Zhaoping Qiu
Qifeng Wang
Jie Ding
Shenglin Huang
Taoyang Chen
Jianren Gu
Ming Yao
Xianghuo He
Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma.
description MicroRNAs (miRNAs) are small, single-stranded, non-coding RNAs that play pivotal roles in human cancer development and progression, such as tumor metastasis. Here, we identified the miRNAs that regulate hepatocellular carcinoma (HCC) cell migration by a high-throughput screening method using the classical wound-healing assay with time-lapse video microscopy and validation with a transwell migration assay. Eleven miRNAs (miR-134, -146b-3p, -188-3p, -525-3p, -661, -767-5p, -891a, -891b, -1244, -1247 and miR-1471) were found to promote or inhibit HCC cell migration. Further investigation revealed that miR-134 suppressed the invasion and metastasis of HCC cells in vitro and in vivo, and integrin beta 1 (ITGB1) was a direct and functional target gene of miR-134. Moreover, miR-134 inhibited the phosphorylation of focal adhesion kinase (FAK) and the activation of RhoA downstream of the ITGB1 pathway, thereby decreasing stress fiber formation and cell adhesion in HCC cells. In conclusion, we demonstrated that miR-134 is a novel metastasis suppressor in HCC and could be a potential therapeutic target for the treatment of HCC.
format article
author Ruopeng Zha
Weijie Guo
Zhenfeng Zhang
Zhaoping Qiu
Qifeng Wang
Jie Ding
Shenglin Huang
Taoyang Chen
Jianren Gu
Ming Yao
Xianghuo He
author_facet Ruopeng Zha
Weijie Guo
Zhenfeng Zhang
Zhaoping Qiu
Qifeng Wang
Jie Ding
Shenglin Huang
Taoyang Chen
Jianren Gu
Ming Yao
Xianghuo He
author_sort Ruopeng Zha
title Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma.
title_short Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma.
title_full Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma.
title_fullStr Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma.
title_full_unstemmed Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma.
title_sort genome-wide screening identified that mir-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/835c6f752bc548d2a04ed466c2e47883
work_keys_str_mv AT ruopengzha genomewidescreeningidentifiedthatmir134actsasametastasissuppressorbytargetingintegrinb1inhepatocellularcarcinoma
AT weijieguo genomewidescreeningidentifiedthatmir134actsasametastasissuppressorbytargetingintegrinb1inhepatocellularcarcinoma
AT zhenfengzhang genomewidescreeningidentifiedthatmir134actsasametastasissuppressorbytargetingintegrinb1inhepatocellularcarcinoma
AT zhaopingqiu genomewidescreeningidentifiedthatmir134actsasametastasissuppressorbytargetingintegrinb1inhepatocellularcarcinoma
AT qifengwang genomewidescreeningidentifiedthatmir134actsasametastasissuppressorbytargetingintegrinb1inhepatocellularcarcinoma
AT jieding genomewidescreeningidentifiedthatmir134actsasametastasissuppressorbytargetingintegrinb1inhepatocellularcarcinoma
AT shenglinhuang genomewidescreeningidentifiedthatmir134actsasametastasissuppressorbytargetingintegrinb1inhepatocellularcarcinoma
AT taoyangchen genomewidescreeningidentifiedthatmir134actsasametastasissuppressorbytargetingintegrinb1inhepatocellularcarcinoma
AT jianrengu genomewidescreeningidentifiedthatmir134actsasametastasissuppressorbytargetingintegrinb1inhepatocellularcarcinoma
AT mingyao genomewidescreeningidentifiedthatmir134actsasametastasissuppressorbytargetingintegrinb1inhepatocellularcarcinoma
AT xianghuohe genomewidescreeningidentifiedthatmir134actsasametastasissuppressorbytargetingintegrinb1inhepatocellularcarcinoma
_version_ 1718421631422955520